Diligence memo · auto-generated · as of July 2, 2026
Future Method, Inc.
Future Method, Inc. looks over-valued against its niche peers and is dormant on financing cadence.
Businessfiled
Future Method, Inc. operates in Other Health Care, based in NEW YORK.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Future Method, Inc. has raised $2.0M in disclosed capital across 3 recorded rounds, aggregated from public filings. Its latest round is modeled as Pre-Seed (a round under $1.0M).
Largest single filing: $850K on 2018-02-07.
Most recent recorded round closed around 2019-07-19.
Valuation (modeled)modeled
Provath models Future Method, Inc. at approximately $15M (range $313K–$175M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Over-valued. Modeled value is 1.90× the median modeled value of Pre-Seed Other Health Care companies in 2019–2021 (295 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Historic cadence: a new round about every 9 months.
Last raise 7.0 yr ago; this sector typically re-raises about every 14 months.
Silent for over 3× the sector's normal cadence.
The last round was 1.3× smaller than the prior — a bridge or down round.
Comparablesmixed
Capital scale ranks ahead of 46% of Other Health Care peers (5376 compared).
Modeled value ranks above 43% of those peers.
Closest niche peers: Aetas Co LLC, Hauppauge SC Holdings, LLC, Gateway IV Lithotripsy, LLC, Endoscopy Center of West Central Ohio, LLC, Dalent LLC.
Peoplefiled
3 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
Modeled above niche peers — valuation risk on entry.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.